SCRI Oncology Partners /ID# 281380

Nashville, Tennessee 37203

1 studies enrolling now · 1 studies all time

What they study most

Relapsed or Refractory Multiple Myeloma

Studies at this site

• A Study to Evaluate Adverse Events and Change in Disease Activity With Injected Etentamig Plus Oral Pomalidomide Versus Standard Therapies in Adults With Relapsed or Refractory Multiple Myeloma — Starting soon